Zobrazeno 1 - 10
of 64
pro vyhledávání: '"A, Lázaro Cebas"'
Autor:
Elsa Izquierdo-García, Andrea Lázaro-Cebas, Berta Montero Pastor, Ana Such Díaz, Elena Alba Álvaro-Alonso, Laura López Guerra, Ismael Escobar-Rodríguez
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background Hereditary fructose intolerance (HFI) is a rare metabolic disease caused by aldolase B deficiency. The aim of our study was to analyse excipient tolerability in patients with HFI and other related diseases and to design mobile and
Externí odkaz:
https://doaj.org/article/348c94edd3684e35a2e486c33e971a66
Autor:
Izquierdo-García, Elsa1 (AUTHOR) elsa.izquierdo@salud.madrid.org, Lázaro-Cebas, Andrea2 (AUTHOR), Montero Pastor, Berta1 (AUTHOR), Such Díaz, Ana1 (AUTHOR), Álvaro-Alonso, Elena Alba1 (AUTHOR), López Guerra, Laura1 (AUTHOR), Escobar-Rodríguez, Ismael1 (AUTHOR)
Publikováno v:
Orphanet Journal of Rare Diseases. 1/5/2024, Vol. 19 Issue 1, p1-9. 9p.
Autor:
Andrea Lázaro Cebas, José Manuel Caro Teller, Carmen García Muñoz, Carlos González Gómez, José Miguel Ferrari Piquero, Carlos Lumbreras Bermejo, José Antonio Romero Garrido, Juana Benedí González
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Patient education on pharmacological treatment could reduce readmissions. Our objective was to carry out a pharmacist intervention focused on providing information about high-risk medications to chronic patients and to analyse its
Externí odkaz:
https://doaj.org/article/f49b14ba5bae4a6899bced58d2d6280b
Autor:
Rosas Espinoza, C., Caro Teller, J.M., Arrieta Loitegui, M., Lázaro Cebas, A., Ortiz Pérez, S., Jiménez Cerezo, M.J., Ferrari Piquero, J.M.
Publikováno v:
In Journal of Healthcare Quality Research September-October 2020 35(5):313-318
Autor:
Lázaro Cebas, Andrea1 (AUTHOR) andrea.lazaro@carm.es, Caro Teller, José Manuel2 (AUTHOR), García Muñoz, Carmen2 (AUTHOR), González Gómez, Carlos3 (AUTHOR), Ferrari Piquero, José Miguel2 (AUTHOR), Lumbreras Bermejo, Carlos3 (AUTHOR), Romero Garrido, José Antonio4,5 (AUTHOR), Benedí González, Juana5 (AUTHOR)
Publikováno v:
BMC Health Services Research. 2/9/2022, Vol. 22 Issue 1, p1-9. 9p. 5 Charts.
Autor:
A Lázaro Cebas, C Rosas Espinoza, S Ortiz Pérez, M Arrieta Loitegui, JM Caro Teller, M. J. Jiménez Cerezo, JM Ferrari Piquero
Publikováno v:
Journal of Healthcare Quality Research. 35:313-318
Resumen Antecedentes y objetivos Los errores de medicacion son el evento adverso mas frecuente de la asistencia sanitaria. La validacion farmaceutica (VF) busca reducirlos. Los objetivos fueron evaluar el impacto de la implementacion de una mejora de
Autor:
E Palencia Herrejon, P Tejedor Prado, JL Fraile González, B Sánchez Artola, I Cañamares Orbis, A Such Díaz, L Cano Alcalde, J Garrido Dorronsoro, E Izquierdo García, I. Escobar Rodríguez, A Lázaro Cebas
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Hospital at home (HaH) units provide hospital level care at home to patients who would otherwise remain hospitalised. This hospitalisation model is growing as it saves costs, reducing hospital stay and complications such as
Autor:
E Palencia Herrejon, EA Álvaro Alonso, E Izquierdo García, B Sánchez Artola, I. Escobar Rodríguez, S Salso Ortiz, A Such Díaz, E Aznar Cano, S Esteban Casado, A Lázaro Cebas, P Tejedor Prado
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance In the absence of evidence about the incidence of bacterial co-infection, antibiotic treatment was widely prescribed to prevent this potential complication Increasing antibiotic consumption could have exerted an ecological p
Autor:
J Lázaro-Cebas, L Gómez-Sayago, L Marín-Ventura, T Rico-Gutierrez, C Cáceres-Velasco, T Criado-Illana, F Ruiz-Molina
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance There has been a transformation in the treatment of HCV infection with the development of direct acting antivirals. However, there are still limited data to recommend treatments in patients with dysphagia or percutaneous end
Autor:
I. Escobar Rodríguez, E Izquierdo García, S Esteban-Casado, I Cañamares Orbis, A Lázaro Cebas, EA Álvaro Alonso, P Tejedor Prado, A Such Díaz, C. Esteban Alba, A. Santiago Pérez
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Over the past 10 years, a pharmacotherapy revolution in the treatment of moderate to severe plaque psoriasis (MS-PP) has occurred. In our country, the prescription of ustekinumab has increased greatly since its approval in 2